Literature DB >> 22119120

Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals: neonatal pulmonary artery rehabilitation without unifocalization.

Matthew Liava'a1, Christian P Brizard, Igor E Konstantinov, Terry Robertson, Michael M Cheung, Robert Weintraub, Yves d'Udekem.   

Abstract

BACKGROUND: This study analyzed a protocol of neonatal rehabilitation of hypoplastic pulmonary arteries in the management of pulmonary atresia, ventricular septal defect (VSD), and major aortopulmonary collateral arteries (MAPCAs). Ideal management of patients with pulmonary atresia, VSD, and MAPCAs is the subject of controversy.
METHODS: From June 2003 to December 2008, 25 consecutive patients were diagnosed with pulmonary atresia, VSD, and MAPCAs, and 20 were entered into a neonatal shunting regimen. The median age at the first operation was 3.6 weeks (range, 0.7 to 17 weeks). All patients underwent an initial central or modified Blalock-Taussig shunt, or both. Further preparatory procedures included 26 pulmonary artery patch reconstructions, 19 right ventricle-to-pulmonary artery conduits, 4 MAPCA ligations, and 4 further shunts. No patient underwent translocation of the collateral arteries.
RESULTS: At the latest follow-up, 12 of 20 patients have had a complete repair at a median age of 18 months (range, 11 to 48 months), 6 are awaiting repair, and 2 are considered unlikely to be repaired. No patient was missing follow-up. Median pulmonary artery indices had grown from 14.51 to 118.7 in 17 patients. Postoperative angiograms were performed at a median of 8 months (range, 1.9 to 32.7 months) in 9 of 12 completely repaired patients. The median right/left ventricular pressure ratio was 0.64 (range, 0.54 to 0.91).
CONCLUSIONS: Rehabilitation of hypoplastic native pulmonary arteries by a neonatal shunting regimen, without MAPCA translocation, for pulmonary atresia, VSD, and MAPCAs, provides encouraging results with excellent early survival.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22119120     DOI: 10.1016/j.athoracsur.2011.08.082

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Importance of multidisciplinary management for pulmonary atresia, ventricular septal defect, major aorto-pulmonary collateral arteries and completely absent central pulmonary arteries.

Authors:  Takaya Hoashi; Satoshi Yazaki; Koji Kagisaki; Masataka Kitano; Masatoshi Shimada; Isao Shiraishi; Hajime Ichikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-03-04

Review 2.  Surgical strategies for pulmonary atresia with ventricular septal defect associated with major aortopulmonary collateral arteries.

Authors:  Akio Ikai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-25

Review 3.  3D Printing Provides a Precise Approach in the Treatment of Tetralogy of Fallot, Pulmonary Atresia with Major Aortopulmonary Collateral Arteries.

Authors:  Shafkat Anwar; Toby Rockefeller; Demetrios A Raptis; Pamela K Woodard; Pirooz Eghtesady
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03

4.  Outcomes of Patients with Pulmonary Atresia and Major Aortopulmonary Collaterals Without Intervention in Infancy.

Authors:  Michael L O'Byrne; Joshua P Kanter; John T Berger; Richard A Jonas
Journal:  Pediatr Cardiol       Date:  2016-07-05       Impact factor: 1.655

5.  Potential Factors Affected Safety and Efficacy of Transcatheter Plug Closure for Pediatric Hemoptysis with Anomalous Bronchial Arteries.

Authors:  Hong-Yu Kuang; Qiang Li; Ping Xiang; Chuan Feng; Qi-Jian Yi; Tie-Wei Lu
Journal:  J Interv Cardiol       Date:  2019-02-19       Impact factor: 2.279

6.  Case 4/2019 - Pulmonary Atresia, Ventricular Septal Defect, and Systemic-Pulmonary Collateral Circulation developing after prior Blalock-Taussig, in a Symptomatic 47-Year-Old Adult.

Authors:  Edmar Atik; Maria Angélica Binotto; Alessandra Costa Barreto; Walther Ishikawa
Journal:  Arq Bras Cardiol       Date:  2019-08-08       Impact factor: 2.000

7.  Homograft durability after correction of pulmonary atresia and ventricular septal defect with or without systemic pulmonary collateral arteries.

Authors:  Pieter C van de Woestijne; Jamie L R Romeo; Ingrid van Beynum; Maarten Witsenburg; M Mostafa Mokhles; Ad J J C Bogers
Journal:  JTCVS Open       Date:  2021-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.